E71.511 Neonatal adrenoleukodystrophy

Name of the Condition

• Neonatal adrenoleukodystrophy

Summary

Neonatal adrenoleukodystrophy is a severe genetic disorder affecting peroxisome biogenesis, a critical cellular process for breaking down fatty acids, producing bile acids, and detoxifying harmful substances. This disruption leads to the accumulation of toxic compounds and deficiency of essential metabolites, resulting in widespread metabolic and neurological dysfunction.

Causes

Neonatal adrenoleukodystrophy is caused by mutations in genes responsible for peroxisome formation or function. These mutations impair the organelle's ability to perform its metabolic roles, leading to the buildup of substances like very long-chain fatty acids or the deficiency of plasmalogens, which are vital for brain and lung function.

Risk Factors

• Family history of peroxisome biogenesis disorders due to autosomal recessive inheritance.
• Consanguineous relationships (parents who are closely related).

Symptoms

• Severe developmental delays or regression.
• Muscle weakness or hypotonia.
• Seizures or abnormal eye movements.
• Liver dysfunction or enlarged liver.
• Abnormal facial features (e.g., high forehead, flattened nasal bridge).
• Vision or hearing impairment.

Diagnosis

Diagnosis involves biochemical testing to measure levels of very long-chain fatty acids, plasmalogens, or other peroxisomal metabolites in blood or urine. Genetic testing may confirm specific mutations, and imaging studies (e.g., MRI) can assess neurological involvement.

Treatment Options

Treatment focuses on managing symptoms and may include dietary modifications, supportive therapies (e.g., physical or occupational therapy), and medications to address seizures or other complications. No cure exists, but early intervention can improve quality of life.

Prognosis and Follow-Up

Prognosis is poor, with most affected infants not surviving beyond the first year of life. Regular follow-up with a multidisciplinary team (neurologists, geneticists, and metabolic specialists) is essential to monitor progression and adjust care.

Complications

• Progressive neurological decline.
• Respiratory failure.
• Liver failure.
• Severe developmental impairment.

Lifestyle & Prevention

• Genetic counseling for families with a history of peroxisome biogenesis disorders.
• Prenatal testing may be considered for at-risk pregnancies.

When to Seek Professional Help

Seek immediate medical attention if an infant shows signs of developmental regression, seizures, or unexplained weakness, as early diagnosis is critical for managing symptoms.

Tips for Medical Coders

Document clinical findings, diagnostic test results, and family history to support coding. Ensure specificity in documentation to align with the ICD-10-CM code E71.511 for neonatal adrenoleukodystrophy.